Stay updated on Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The prior lapse-in-government-funding operating-status notice was removed.
    Difference
    0.4%
    Check dated 2026-02-11T00:27:42.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide funding/operating status notice has been added, and the site version has been updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T22:44:14.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now shows a glossary option and includes meta-data updates: the 'Last Update Submitted that Met QC Criteria' label and a 'No FEAR Act Data' note were added, and the site revision updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T18:00:54.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No changes to study content or critical functionality were observed.
    Difference
    0.1%
    Check dated 2026-01-20T14:18:52.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added a Locations section highlighting Texas (Houston, MD Anderson Cancer Center) for the study, removed the old Texas Locations block and the HHS Vulnerability Disclosure link, and updated the revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-22T10:24:03.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.3.1 to v3.3.2; no study content or critical details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T15:55:20.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.